InvestSMART

Epsilon Healthcare Limited (ASX: EPN) - Announcements

- Current share price for EPN : $0.025

ASX company news and announcements for Epsilon Healthcare Limited (EPN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Epsilon Healthcare Limited (EPN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Epsilon Healthcare Limited (EPN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Epsilon Healthcare Limited (EPN)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$10 Shareholder Update 28 Sep 2026 9:14AM $0.028 $0.025 fallen by 10.71%
$10 Update to Appendix 4C Managing Director Loan 25 Sep 2026 8:16AM $0.028 $0.025 fallen by 10.71%
$10 Change of Director's Interest Notice - Zoe Hutchings 17 Sep 2026 4:11PM $0.029 $0.025 fallen by 13.79%
$10 Epsilon Progresses Global Manufacturing Opportunity 15 Sep 2026 9:28AM $0.025 $0.025 fallen by 0%
$10 Change of Director's Interest Notice - Alan Beasley 10 Sep 2026 4:13PM $0.025 $0.025 fallen by 0%
$10 Half Yearly Report and Accounts 31 Aug 2026 5:44PM $0.021 $0.025 risen by 19.05%
$10 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2026 1:27PM $0.023 $0.025 risen by 8.70%
$10 Change in substantial holding 9 Jul 2026 8:20AM $0.022 $0.025 risen by 13.64%
$10 Becoming a substantial holder 8 Jul 2026 4:24PM $0.022 $0.025 risen by 13.64%
$10 Change of Director's Interest Notice - Zoe Hutchings 6 Jul 2026 6:58PM $0.022 $0.025 risen by 13.64%
$10 Company Debt Arrangements - update 30 Jun 2026 5:48PM $0.022 $0.025 risen by 13.64%
$10 Closure of small holding share sale facility 26 Jun 2026 4:49PM $0.022 $0.025 risen by 13.64%
$10 Notification regarding unquoted securities - EPN 9 Jun 2026 9:50AM $0.023 $0.025 risen by 8.70%
$10 Change of Director's Interest Notice - Peter Giannopoulos 9 Jun 2026 8:12AM $0.023 $0.025 risen by 8.70%
$10 Change of Director's Interest Notice - Alan Beasley 9 Jun 2026 8:12AM $0.023 $0.025 risen by 8.70%
$10 Results of Meeting 29 May 2026 4:23PM $0.024 $0.025 risen by 4.17%
$10 Change of Director's Interest Notice - Alan Beasley 11 May 2026 2:02PM $0.020 $0.025 risen by 25%
$10 Small holding share sale facility 8 May 2026 4:20PM $0.020 $0.025 risen by 25%
$10 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2026 9:36AM $0.020 $0.025 risen by 25%
$10 Notice of Annual General Meeting/Proxy Form 29 Apr 2026 11:53AM $0.020 $0.025 risen by 25%
$10 Update on proceedings against former director 14 Apr 2026 1:34PM $0.021 $0.025 risen by 19.05%
$10 Annual Report to shareholders 31 Mar 2026 8:15PM $0.021 $0.025 risen by 19.05%
$10 Appendix 4G & Corporate Governance Statement 31 Mar 2026 12:14PM $0.021 $0.025 risen by 19.05%
$10 Preliminary Final Report 27 Feb 2026 5:22PM $0.026 $0.025 fallen by 3.85%
$10 Establishment of New Epsilon Biotech Subsidiary 18 Feb 2026 8:27AM $0.028 $0.025 fallen by 10.71%

1 - 25 of 253 results

Page 1 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.